We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Suits Can't Survive Omnicare Ruling, 2nd Circ. Says

Law360, New York (March 4, 2016, 2:23 PM EST) -- The Second Circuit on Friday refused to revive a pair of securities class actions against drugmaker Sanofi over the rollout of its multiple sclerosis treatment Lemtrada, saying last year’s Omnicare ruling...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.